ASCO/ESMO 2020 - Head and Neck Cancer Updates - JAVELIN100 Trial Update

ASCO/ESMO 2020 PembroRAD Trial UpdateПодробнее

Curative Modalities & Immunotherapy for Head & Neck Cancer - 2021 ASCO ESMO Head & Neck RecapПодробнее

Update on Head and Neck Cancer from ASCO 2020Подробнее

Recent Data, Developments in Palliative Cancer Treatments - 2021 ASCO ESMO Head & Neck RecapПодробнее

ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned?Подробнее

ASCO/ESMO 2020 Debio 1143/ Xevinapant Study UpdateПодробнее

ASCO/ESMO 2020 - The Future of Head and Neck Cancer TreatmentПодробнее

JAVELIN Bladder 100 trial updates from ASCO 2021Подробнее

Head & Neck Cancer Updates from ESMO 2021Подробнее

ASCO 2024 Top 3 Practice Changing Head & Neck Cancer StudiesПодробнее

HPV and Head and Neck Cancers - 2021 ASCO ESMO Head & Neck RecapПодробнее

ESMO 2020 Highlights on pembrolizumab in LA-HNSCC: The GORTEC 2015-01 “PembroRad” studyПодробнее

Head and neck updates at ACSO 2023Подробнее

ESMO 2022 highlights in head and neck cancerПодробнее

Head & Neck Cancer Updates from ESMO 2021Подробнее

#ESMO23 Head and neck cancer Track highlights with Chair Paolo BossiПодробнее

Head and neck cancer highlights at ASCO 2021Подробнее

JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancerПодробнее